Enterprise researchers can now legally use generative AI to mine paywalled scientific papers without infringing copyright – so long as they buy a newly launched licensing add-on. Research Solutions (NASDAQ: RSSS) today announced the commercial release of “AI Rights,” a rights-management layer for its Article Galaxy research platform. The add-on promises to end the legal grey area that has surrounded corporate use of large language models (LLMs) on proprietary journal content by allowing instant verification, one-click rights acquisition, and retroactive licensing of AI‑use permissions at scale.

R&D teams in pharma, biotech, and engineering have been racing to apply ChatGPT, Copilot, and Claude to literature review, hypothesis generation, and data synthesis. The speed is seductive: an LLM can summarise thousands of papers in hours. But most scientific journals are locked behind complex publisher licences that either forbid or are silent on machine use. Research Solutions calls this a “compliance paradox” – researchers want the productivity of AI but cannot risk a copyright strike with every query. The AI Rights add‑on is designed to resolve that paradox by baking copyright compliance directly into the literature procurement workflow.

How AI Rights Works

The add‑on sits inside Article Galaxy, a platform already used by many corporate libraries to source and manage scientific, technical and medical (STM) content. When a researcher calls up an article, the interface now displays a machine‑readable licence status: permitted, restricted, or unlicensed for AI analysis. If rights are missing, a “Buy AI Rights” button lets the user purchase the necessary permission at a publisher‑set price. Licences are enterprise‑wide, not tied to a single user, and can be applied retroactively to articles an organisation already owns.

Research Solutions lists five core capabilities:

  • Instant rights verification – shows whether feeding an article into an LLM is allowed under the current licence.
  • Comprehensive rights management – aggregates open-access licences, Reproduction Rights Organisation agreements, direct publisher deals, and marketplace acquisitions in one view.
  • One‑click rights acquisition – purchase AI‑use rights transparently without leaving Article Galaxy.
  • Retroactive rights purchase – buy permissions for articles already in the corporate library to achieve immediate compliance.
  • Organization‑wide licensing – the acquired right covers the whole enterprise, eliminating per‑user friction.

The company also highlights integration with Microsoft Copilot, ChatGPT, and Anthropic’s Claude, so that once a paper is licensed, its text can safely flow into these tools while maintaining an auditable compliance chain.

Why Enterprises Should Care

The business case is straightforward. Legal risk is the single biggest brake on enterprise AI adoption for R&D. Recent high‑profile litigation over training data and the uncertain boundaries of fair use or text‑and‑data‑mining exceptions have made general counsels nervous. A platform that provides documented, per‑article licences for AI use removes that hesitation, Research Solutions argues. The firm claims that “76% of researchers who now use AI tools… lack clear guidance on copyright permissions” – a statistic drawn from its own press release, though no independent survey is cited.

By centralising rights decisions, the add‑on promises to slash the time legal and procurement teams spend chasing permissions. It creates a single audit trail and licence registry inside the research platform, which is critical when downstream AI outputs influence patent filings, regulatory submissions, or product claims. Publishers, meanwhile, gain a new revenue stream from a use that was previously hard to commercialise.

Strengths: Real Operational Value

If the add‑on works as advertised, it fills a gap that has frustrated corporate research teams for years. The ability to check a licence and buy a machine‑use right in one interface is a genuine productivity boost. The retroactive licensing feature lets companies remediate legacy content libraries – a practical necessity given that most data‑science teams already have thousands of PDFs on internal servers.

Perhaps most important, the product aligns economic incentives. Publishers are paid for broader machine use, while enterprises gain legal certainty. This mutual benefit, if scaled, could become a sustainable model for AI‑era scientific publishing.

Limitations and Unanswered Questions

Despite its promise, the add‑on is not a plug‑and‑play solution for all AI‑related copyright worries. Several gaps remain:

  • Publisher participation is opaque. The public announcement mentions “major publishers” but provides no master list. Buyers must verify independently whether the journals they need are covered. Without broad buy‑in, the solution fragments.
  • Pricing at scale is unclear. One‑click purchasing works for ad‑hoc needs, but an enterprise running thousands of AI queries per week needs predictable, volume‑based pricing. The press release touts transparency, but large‑scale or training‑related use will likely require custom deals.
  • The inference vs. training divide is critical. The add‑on appears focused on AI analysis – e.g., summarising a paper or answering questions from it. It does not explicitly cover using the content for model training or fine‑tuning. Organisations that want to build proprietary models on licensed literature must negotiate that right separately with each publisher.

Even a valid licence does not eliminate all exposure. If an LLM regurgitates substantial copyrighted text from a licensed article, that output could still infringe other rights or combine with unlicensed material. Human review of outputs remains essential, especially for material used in regulatory filings or patent prosecution.

Jurisdictional variance adds another layer. A U.S.‑centric licence may not hold in EU courts, where text‑and‑data‑mining exceptions operate differently. Multinational companies must map rights to local legal regimes – a task the add‑on alone cannot perform.

Recordkeeping is the final piece. Courts and regulators will expect demonstrable logs of what was licensed, when, and for what purpose. The add‑on’s audit trail is a strength, but it must be exportable and integrated with enterprise retention policies. IT teams need to store prompts, outputs, and licence tokens together to build a defensible record.

What Windows‑Focused IT Teams Must Do

Because AI Rights integrates with Copilot and other enterprise AI tools, it touches Windows, Azure AD, SharePoint, and the broader Microsoft 365 security stack. Windows admins should prepare for a controlled pilot by focusing on four areas:

  • Connector security: Ensure that Article Galaxy connectors to corporate document repositories (SharePoint, file servers, DMS) respect role‑based access controls. Misconfigured connectors remain a top cause of data leakage when AI tools are enabled.
  • Identity and access: Tie AI Rights purchases and usage to Azure AD identities and conditional access policies. This ensures licence obligations map to organisational roles and that only authorised users can buy rights.
  • Data flow controls: Use Microsoft Purview sensitivity labels or DLP rules to block sending unlicensed content to public LLM endpoints. The licence must be checked automatically before content leaves the enterprise perimeter.
  • Logging and retention: Turn on detailed audit logs for Copilot and related services. Preserve licence tokens, prompts, and outputs for the period legal counsel recommends – usually years, given the long tail of IP litigation.

These measures transform the licence from a legal formality into an enforceable technical control.

Market Context

Research Solutions is not alone. The push for structured AI‑rights marketplaces is part of a broader industry shift. Publishers are building their own AI products, while provenance and dataset‑auditing firms are emerging. What makes the AI Rights add‑on notable is its embedding within a platform already used by corporate researchers, lowering the adoption barrier.

If the model takes off, it could reshape STM content economics. Publishers get a predictable revenue stream from machine use; enterprises get speed and legal cover; LLM platform vendors like Microsoft and OpenAI get a larger corpus of high‑quality, cleared content for lawful analysis. Training rights, however, will remain a separately negotiated commodity, as the value of training corpora far exceeds that of one‑off inference.

Practical Guidance for Buyers

Before committing, enterprise IT and legal teams should run a rigorous evaluation:

  • Confirm publisher coverage – get a written list of participating publishers and the specific journals covered.
  • Clarify permitted uses – insist on contract language that distinguishes between AI analysis (inference), model training, and fine‑tuning, with clear territorial rights.
  • Test pricing at volume – request enterprise quotes for the expected number of AI queries and for bulk retroactive licences.
  • Integrate licence metadata – ensure licence status flows into DLP tags, sensitivity labels, and AI gateways so that only licensed content reaches LLM endpoints.
  • Build the audit trail – log every AI interaction linked to a licence token and retain those logs in a tamper‑proof, exportable format.

Bottom Line

Research Solutions’ AI Rights add‑on is a pragmatic product that addresses a genuine operational and legal pain point. It could materially accelerate AI adoption in life sciences and other R&D‑intensive sectors by converting speculative copyright exposure into manageable, auditable processes. But it is no legal panacea. Licence tokens mitigate unauthorised machine use of specific articles; they do not immunise organisations from all output‑related claims, model‑training risks, or cross‑jurisdictional headaches.

Enterprise customers should welcome the innovation but approach it with eyes wide open. A successful deployment requires more than a purchase order – it demands a governance programme that marries the add‑on’s rights management with Windows‑native security controls, human review, and ongoing legal oversight. Done right, the combination could unlock the full productivity of generative AI on scientific literature while keeping compliance firmly in check.